⚠️ Ordering Limits (from 1st Sept)
✅ You can only order from Lotus if you’ve had 2 pens or less in the last 28 days.
🚫 If you’ve already had 3 or more pens in the last 28 days, your order will be cancelled & refunded.
⏳ Please note: Due to high demand, orders may take up to 1-2 days to process.
Follow us on Instagram for updates.
GLP-1 Maintenance
You’ve put in serious work. Now let’s protect your results. Together we’ll decide whether to continue, reduce, taper or stop. We’ll also give you a simple plan you can actually follow.
Keep your results on the lowest effective weekly dose.
Most people can maintain on 1.7mg or 2.4mg weekly.
Ozempic is Semaglutide licensed for type 2 diabetes.
Clinician message
Patient testimonials
Patients of Lotus weight loss consistently rate us 5 stars. Here’s what some of those patients have to say.
No one‑size‑fits‑all. We’ll pick the route that feels sustainable, and change it later if life changes.
We look at your goals, dose tolerance, appetite, side‑effects and plans (e.g., pregnancy). We choose the least medication that keeps you well.
Absolutely. We review at 8-12 weeks and can switch paths.
Yes. We move one step at a time and set a safety net (when to step back up and how to contact us).
We aim for the lowest effective dose that keeps weight and appetite steady. That’s kinder on your body and your wallet. (We’ll consult with you to personalised your dose)
| Treatment | Typical maintenance range | Step‑down examples | Review cadence |
| Semaglutide (Wegovy) | 1.7 or 2.4mg once weekly | 2.4 → 1.7mg | Review every 8-12 weeks |
| Tirzepatide (Mounjaro / Zepbound) | 5, 10 or 15mg once weekly (can be higher) | 15 → 10mg or 10 → 5mg | Review every 8-12 weeks |
| We can prescribe any licensed dose that works for you | |||
No. ‘Best’ is the lowest dose that keeps you stable. Many maintain well on 1.7mg, but that isn’t always the case. Our clinicians can prescribe whatever maintenance dose works best for you.
We pick the nearest tier and let the review data guide the next step.
There’s no fixed rule in private care; NHS commissioning for Wegovy is up to 2 years in specialist services. We’ll personalise your plan.
Clinic note: There isn’t a single ‘right’ answer here. We’ll agree a plan, check‑in at 8-12 weeks and adjust. If we taper, we’ll add extra monitoring and lifestyle support.
Not always, but regain is common among patients who do not seek ongoing weight loss support along in conjunctions with your medication. That’s why we agree a safety net and act early if needed.
Current data supports ongoing use when tolerated well, with routine monitoring as an extra precaution.
Some people prefer the least medication possible; tapering tests whether that works for you.
These are non‑negotiable for GLP-1 maintenance safety and simple once you know them.
Please don’t. Plan to stop your treatment before trying (2 months for Semaglutide; 1 month for Tirzepatide).
Use a non‑oral method or add condoms for 4 weeks after starting and after each escalation.
This is not recommended in any capacity. Book a consultation with us so we can talk it through.
Small day‑to‑day changes are normal. We act when there’s a pattern.
Our trigger for action:
What to do:
Focus on the 4-8 week trend, not a single day. If you’re unsure, book a short review.
Many feel appetite improve within 1-2 weeks of stepping up the dose. We’ll also reassess at 4-8 weeks.
Usually no. One tier up is enough unless there’s been a long break or tricky side‑effects.
Supporting your transition
Use our live chat, contact form or email us at support@lotusweightloss.co.uk and we’ll support you every step of the way.
Clinic note: If you’ve missed 2 weeks or more it’s important you contact us before restarting as you may need to step down and re‑titrate.
Common questions
There is no fixed time limit. We decide together based on:
For your weight trend aim for stable within plus or minus 2kg over 8 to 12 weeks. If you are steady and comfortable, stay on the lowest effective dose with reviews every 8 to 12 weeks.
If your BMI is below 25, avoid increasing the dose unless your clinician records a clear reason. NHS use of Wegovy is usually up to 2 years in specialist services. Private care can differ but still follows a safety-first approach.
Look for clear signals over 4 to 8 weeks:
If watch-outs show up, we may try 2.4mg and review in 4 to 8 weeks. If there is no clear benefit or side effects rise, we step back to 1.7mg.
The fear is common among patients. We reduce by one step only and set a safety net before you start:
If the trigger is hit, you can step back up one dose and message us. Early action beats months of drift.
Sometimes, yes, but only with a plan:
Evidence for tapering is limited, so we monitor closely. If your hunger or weight starts to drift, we pause or step back up. Planning pregnancy?
Stop at least 2 months before trying if on Semaglutide, or at least 1 month if on Tirzepatide.
For Wegovy, NHS services currently allow up to 2 years in eligible patients. Outside the NHS, duration depends on clinical benefit, tolerability and your goals, with reviews every 8 to 12 weeks. In all settings we use the lowest effective dose and put safety first.
Possibly, and sometimes it is the right move, for example due to side effects, supply, or limited progress. Any switch needs:
NHS medicine information
NICE clinical guidelines
Professional certifications
Key clinical trial programmes
—James Reynolds
Lead Clinical Pharmacist, Lotus Weight Loss Clinic
James is a UK-registered pharmacist with over 15 years’ experience in NHS and private healthcare. He specialises in weight management and GLP-1 prescribing, and holds SCOPE certification in obesity care — a globally recognised standard for evidence-based treatment. More about James
Login to reorder..
